Category: Forbes

Biogen Looks To Bulk Up Rare Disease Portfolio With $7.3 Billion Acquisition

Biogen will buy Reata Pharmaceuticals and its Friedreich’s ataxia drug in a $7.3 billion deal.

Centene Profits Hit $1 Billion On Big Obamacare Growth

Centene reported second quarter profits of $1 billion as membership grew by nearly 2 million thanks to Obamacare enrollment.

Centene Profits Hit $1 Billion On Big Obamacare Growth

Centene reported second quarter profits of $1 billion as membership grew by nearly 2 million thanks to Obamacare enrollment.

More Americans Face Possibly Life-Threatening Red Meat Allergy After Spike In Tick-Borne Illness

The condition, alpha-gal syndrome, is usually caused by a bite from the lone star tick—a type of tick indigenous to a majority of the eastern U.S.

Walgreens CFO To Leave As Company Looks For Replacement With Healthcare Experience

Walgreens said chief finance officer James Kehoe will leave the drugstore giant and the company will begin to search for a replacement with healthcare experience.

Doctors Are Leaving Academic Medicine. Most Of Them Are Female

Female physicians are leaving academic medicine at high rates. In the setting of a national physician shortage, this may not bode well for patients.

Multimillionaire Psychologist Wins Bid To Repurchase Her Bankrupt Chain Of Autism Therapy Centers

The Center for Autism and Related Disorders was worth $600 million when Doreen Granpeesheh sold it to Blackstone in 2018 for a big payout. On Wednesday, she received court approval to repurchase the now-bankrupt firm for less than $50 million—and has n…

McConnell’s Abrupt Freeze-Up Could’ve Been A Seizure Or Stroke—Or Just Dehydration, Experts Say

This is the third medical incident McConnell has suffered from this year, as he experienced a fall in March and February.

Ryan Breslow’s Health Startup Sued Over Alleged Trademark Breach

Love Wellness, a lifestyle company founded by TV star Lauren Bosworth, has filed a lawsuit against the Bolt executive chairman’s new startup Love Health.

Whole Genome Sequencing More Effective Than Targeted Gene Sequencing For Diagnosing Genetic Disorders In Newborns

A new national study has found whole genome sequencing to be nearly twice as effective as a targeted gene sequencing test.